Abstract：
BACKGROUND: Injectable poly-L-lactic acid (PLLA) has been proven safe and effective with numerous medical applications for more than 25 years. The product has been approved in over 40 countries and is being used for soft tissue augmentation in the face and certain body parts. With the increased demand for subtle and natural-looking aesthetic treatments in the Asia-Pacific region, there is also a heightened need for consistent preparation and effective treatment methodologies to optimize outcomes for Asian patients.
METHODS: The body of evidence in medical literature, clinical data of presented case reports, and the collective experience of the authors are reflected in these consensus recommendations, which also take under consideration the availability of biostimulators in the Asia-Pacific region.
RESULTS: The resulting consensus recommendations include patient selection and assessment, management of treatment expectations, appropriate preparation and storage, proper injection techniques and treatment plans, management of adverse effects, PLLA combination with other facial rejuvenation procedures, and other constructive considerations.
CONCLUSIONS: In the above consensus recommendations, the authors shared their best practices in accordance with the updated preparation and treatment protocols of PLLA. These recommendations represent the clinical and real-world techniques utilized by authors in providing PLLA treatments for Asian patients.
METHODS: The body of evidence in medical literature, clinical data of presented case reports, and the collective experience of the authors are reflected in these consensus recommendations, which also take under consideration the availability of biostimulators in the Asia-Pacific region.
RESULTS: The resulting consensus recommendations include patient selection and assessment, management of treatment expectations, appropriate preparation and storage, proper injection techniques and treatment plans, management of adverse effects, PLLA combination with other facial rejuvenation procedures, and other constructive considerations.
CONCLUSIONS: In the above consensus recommendations, the authors shared their best practices in accordance with the updated preparation and treatment protocols of PLLA. These recommendations represent the clinical and real-world techniques utilized by authors in providing PLLA treatments for Asian patients.
摘要：
背景：可注射聚-L-乳酸（PLLA）已被证明在许多医学应用中安全有效，已有25年以上。该产品已在40多个国家/地区获得批准，并用于面部和某些身体部位的软组织增强。随着亚太地区对微妙和自然的美容治疗的需求增加，对于一致的准备和有效的治疗方法的需求也越来越高,以优化亚洲患者的结局.
方法：医学文献中的大量证据，提供的病例报告的临床数据，作者的集体经验反映在这些共识建议中，其中还考虑到亚太地区生物刺激器的可用性。
结果：由此产生的共识建议包括患者选择和评估，治疗期望的管理，适当的准备和储存，适当的注射技术和治疗计划，不良反应的管理，PLLA与其他面部年轻化程序的组合，和其他建设性的考虑。
结论：在上述共识建议中，作者根据最新的PLLA准备和治疗方案分享了他们的最佳实践.这些建议代表了作者在为亚洲患者提供PLLA治疗时使用的临床和现实世界技术。
方法：医学文献中的大量证据，提供的病例报告的临床数据，作者的集体经验反映在这些共识建议中，其中还考虑到亚太地区生物刺激器的可用性。
结果：由此产生的共识建议包括患者选择和评估，治疗期望的管理，适当的准备和储存，适当的注射技术和治疗计划，不良反应的管理，PLLA与其他面部年轻化程序的组合，和其他建设性的考虑。
结论：在上述共识建议中，作者根据最新的PLLA准备和治疗方案分享了他们的最佳实践.这些建议代表了作者在为亚洲患者提供PLLA治疗时使用的临床和现实世界技术。
